The proto-oncoprotein KR-POK represses transcriptional activation of CDKN1A by MIZ-1 through competitive binding
Oncogene
|June 13, 2017
Abstract:
This corrects the article DOI: 10.1038/onc.2011.331.
Insights
This study corrects a previously published article DOI. The correction ensures accurate citation and referencing for future research in the field.
Area of Science:
- Scientific publishing
- Scholarly communication
- Research integrity
Background:
- Accurate citation is crucial for scientific integrity.
- Maintaining correct article identifiers ensures proper referencing.
- Published research requires consistent and verifiable metadata.
Purpose of the Study:
- To provide a correction for an article DOI.
- To ensure the accuracy of the scientific record.
- To facilitate correct retrieval of the research article.
Main Methods:
- Identifying the incorrect DOI.
- Issuing a formal correction notice.
- Updating the article's metadata.
Main Results:
- The article DOI has been corrected.
- The scientific record is now accurate.
- Researchers can now cite the article correctly.
Conclusions:
- This correction upholds the standards of scholarly publishing.
- Accurate DOIs are essential for the scientific community.
- Ensuring data integrity benefits all researchers.
Related Concept Videos
Inhibition of Cdk Activity
6.1K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Abnormal Proliferation
5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K
Negative Regulator Molecules
38.7K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.7K
Positive Regulator Molecules
7.0K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
7.0K
Positive Regulator Molecules
136.8K
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
136.8K


